龙8 - long8 (国际)唯一官方网站
Home
About
Capabilities
R&D
Investors
News
Careers
简
繁
Home
About
Capabilities
R & D
Investors
News
Careers
Press Release
Press Release
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017
Aug 20, 2021
Mabwell Receives IND Clearance from FDA for Initiating Clinical Trials for its Anti-CD47/PD-L1 Bispecific Antibody
?
Aug 10, 2021
NMPA Accepted IND Application of China's First Anti-Nectin-4 ADC Drug
?
Aug 02, 2021
Mabwell Was Included in the "List of New and Innovative Chinese Pharmaceutical Forces 2021"
?
Jul 21, 2021
Mabwell's Anti-CD47/PD-L1 Bispecific Antibody 6MW3211 Receives IND Approval in China
?
Jul 20, 2021
Activity Review | Harmony and Advancement, Deep Cultivation and Empowerment - Mabwell The 4th Science & Technology Conference
?
Jul 09, 2021
Mabwell and Fudan University Shanghai Cancer Center Announce Strategic Cooperation
?
Jul 08, 2021
Mabwell was included into the 2021 Chinese Pharmaceutical Talent Brand
?
Jul 02, 2021
Mabwell awarded the certificate of Recognised Employer of CPA Australia
?
Jun 04, 2021
Nature Index 2021 Annual Tables: Mabwell Ranks in the Top 10 Chinese Institutions in Life Sciences for the First Time
?
May 27, 2021
Mabwell and Yangtze River Pharmaceutical Reached Strategic Cooperation on the Rights and Interests of Two Innovative Biologics in China
?
Previous
1
2
3
Next
【网站地图】
【sitemap】
